Potential drug–drug interactions in males living with HIV who use drugs to treat lower urinary tract symptoms
Open Access
- 8 June 2023
- journal article
- research article
- Published by Wiley in HIV Medicine
- Vol. 24 (10) , 1083-1087
Abstract
Objective: Lower urinary tract symptoms (LUTS) are becoming more prevalent in the ageing population of males living with HIV. Drugs to treat LUTS are known for both their potential role as victims in drug–drug interactions (DDIs) and their side effects. We aimed to evaluate the current use of drugs to treat LUTS and to assess potential DDIs in our cohort of adult males living with HIV.Design: This was a retrospective review of pharmacy records.Methods: We recorded the combination antiretroviral therapy (cART) regimen and any use of drugs to treat LUTS (anatomical therapeutic chemical codes G04CA/CB/CX and G04BD). Potential DDIs were assessed using the interaction checker developed by the University of Liverpool (https://www.hiv-druginteractions.org/checker).Results: A total of 411 adult males living with HIV were included in this analysis. The median (interquartile range [IQR]) age was 53 (41–62) years. Nineteen (4.6%) patients used one or more drugs to treat LUTS. As expected, older patients were more likely to be receiving treatment for LUTS: Q1 (20–40 years) = 0%; Q2 (41–52 years) = 2%; Q3 (53–61 years) = 7%; Q4 (62–79 years) = 10%. Seven potential DDIs between cART and LUTS treatment were noted in six of the 19 (32%) patients. Following medication reviews of these six patients, the following interventions were proposed: evaluate safe use of alpha‐blocker (n = 4), change in cART (n = 2), and dose reduction of the anticholinergic agent (n = 1).Conclusion: Treatment for LUTS coincided with cART in 7%–10% of patients aged above the median age of 53 years in our cohort. Improvements in DDI management appeared to be possible in this growing cohort of males living with HIV and with LUTS.Keywords
This publication has 9 references indexed in Scilit:
- Analysis of inappropriate prescribing in elderly patients of the Swiss HIV Cohort Study reveals gender inequityJournal of Antimicrobial Chemotherapy, 2020
- Prescribing issues in elderly individuals living with HIVExpert Review of Clinical Pharmacology, 2019
- The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 – 74 years and more than 75 yearsBMC Geriatrics, 2018
- A Pharmacist‐Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older HIV‐Positive PatientsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2017
- Drug interactions between antiretrovirals and drugs used to treat benign prostatic hyperplasia/lower urinary tract symptomsExpert Opinion on Drug Metabolism & Toxicology, 2016
- Incidence of benign prostate hypertrophy in Danish men with and without HIV infectionAIDS, 2015
- Polypharmacy, Drug–Drug Interactions, and Potentially Inappropriate Medications in Older Adults with Human Immunodeficiency Virus InfectionJournal of the American Geriatrics Society, 2014
- The pharmacokinetic evaluation of mirabegron as an overactive bladder therapy optionExpert Opinion on Drug Metabolism & Toxicology, 2013
- Pharmacokinetic Effect of Ketoconazole on Solifenacin in Healthy VolunteersBasic & Clinical Pharmacology & Toxicology, 2006